Navigation Links
Neogen Acquires VeroMara from GlycoMar Ltd.
Date:6/20/2011

LANSING, Mich., June 20, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd.

Based in Oban, Scotland, VeroMara offers testing services to the shellfish and salmon aquaculture industries. VeroMara's services include testing for shellfish toxins, general foodborne pathogens, including E. coli, noroviruses, and salmon husbandry. VeroMara recorded revenues of approximately $800,000 (U.S.) in its most recently completed fiscal year. Terms of the acquisition were not disclosed.

"The acquisition of VeroMara deepens Neogen's advancement into the aquatic sciences," said James Herbert, Neogen's CEO and chairman. "VeroMara's services are complementary and a nice fit with our existing product lines for the seafood industry, including one of our biggest food safety diagnostic products — our histamine tests for the tuna industry. The VeroMara purchase also provides Neogen with key collaborative relationships with influential aquaculture partners, and increased access to important international markets.

"Our new operation in Oban will work in close cooperation with our Neogen Europe headquarters in Ayr, Scotland, providing expanded products and services to a larger customer base," Herbert continued. "Our sales and marketing operations in Ayr have the capability to expand VeroMara's business to several other European countries."

"The sale of our VeroMara testing service allows GlycoMar to focus on our core business — marine natural product research and development," said Dr. Charles Bavington, GlycoMar's managing director. "We are pleased to have VeroMara join Neogen, a company we respect as being one of the world leaders in food safety. This transition will guarantee uninterrupted quality service to our customers."


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. William T. Boehm Joins Neogens Board of Directors
2. Neogen Reports 27% Increase in Quarterly Net Income
3. Neogens Rapid Test for Salmonella enteritidis Receives FDA Approval
4. Neogen Names Quinlan as CFO
5. Neogen Reports 33% Increase in Net Income
6. Neogen Corporation Announces 2nd Quarter Results Conference Call
7. Neogens Rapid Test for Salmonella enteritidis Receives AOAC Approval
8. NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010
9. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
10. Neogen Corporation Announces 3rd Quarter Results Conference Call
11. Neogen Reports 18% Increase in Net Income
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, ... provider of health care services and one of ... today announced that its parent company and sole ... agreement with Medical Properties Trust, Inc. ("MPT") (NYSE: ... for $900 million in cash.  The transaction is expected to ...
(Date:7/27/2015)... ... 2015 , ... This is a professional and in-depth study ... of the industry including definitions, classifications, applications and industry chain structure. The Biophotonics ... analysis, and key regions development status. Development policies and plans are discussed as ...
(Date:7/27/2015)... Wis. (PRWEB) , ... July 27, 2015 , ... ... and facility identification solutions, today announced a new video: 3 Ways to ... OSHA’s Hazard Communication Standard and the Globally Harmonized System (GHS) by effectively labeling ...
(Date:7/27/2015)... Research presented at the 2015 AACC Annual Meeting & ... led to a fingerprick Ebola test becoming the first ... approval from the World Health Organization (WHO). This test ... West Africa by identifying suspected Ebola ... and treat these patients much faster than is currently ...
Breaking Biology Technology:Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Brady Releases “3 Roads to GHS Labels” Video 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... , , , ... NovaBay(R) Pharmaceuticals, Inc. (NYSE-AMEX: NBY ) ( http://www.novabaypharma.com ... the treatment or prevention of a wide range of bacterial, ... Chairman and Chief Executive Officer, will present at the Jesup ...
... Today GenVec, Inc. (Nasdaq: GNVC ) announced ... Vaccine Initiative (MVI) to support the development of vaccines to ... at approximately $2 million, will continue a collaboration that began ... novel adenovirus-based vaccines. Based on the results of the feasibility ...
... , , , ... biotechnology company discovering and developing innovative treatments for pain, announced ... of physiology at the University of California, San Francisco, and ... Solace,s scientific advisory board. , , ...
Cached Biology Technology:NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 2NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 3GenVec Expands Contract Supporting Malaria Vaccine Program 2GenVec Expands Contract Supporting Malaria Vaccine Program 3Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board 2Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board 3
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
(Date:7/13/2015)... Conn. , Jul. 13, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/188684 for ... achieves another new convenient and secure method to ... new, innovative payment methods, introduced with its groundbreaking ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Fats in our stomach may reduce the protective effects ... University of Glasgow found that in the presence of ... (the active component of vitamin C), to protect against ... is less than when no lipids are present. “Our ...
... Al Gore's film, An Inconvenient Truth, has generated greater ... the more rapid warming that has occurred within major ... 10 degrees hotter than their surroundings. These metropolitan hot ... can stress the animals and plants that make their ...
... form of vitamin A used to treat acute promyelocytic leukemia ... microRNAs (miRNAs) in the leukemic cells. , The study also ... two genes important for cancer development, helping to explain how ... called all-trans-retinoic acid (ATRA) and it is considered the gold ...
Cached Biology News:City ants take the heat 2Leukemia drug turns mini-molecules up, cancer genes down 2
Economical and manually filled LN2 vacuum insulated storage container offers high capacity and low nitrogen consumption while offering convenient storage of samples....
... DNase I Amplification Grade ... DNA to oligodeoxyribonucleotides. The ... units/mg. DNAse I Amplification ... and tested for absence ...
... Collection of Cell Cultures (ECACC) in conjunction ... the West of England, Bristol, UK, have ... control of HER2, oestrogen and progresterone receptor ... sections of formalin fixed, breast cancer cell ...
... Recombinant type 14 3C protease from human ... to the Novagen brand line of restriction ... highly purified recombinant 6XHis-fusion protein, which recognizes ... enzyme: LeuGluValLeuPheGln/GlyPro. The small, 22 KDa size ...
Biology Products: